Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BPH ENERGY LTD Board/Management Information 2008

Sep 18, 2008

64555_rns_2008-09-18_a8d06b64-415f-4379-93b0-88922708cb51.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [143 x 63] intentionally omitted <==

19 September 2008 BioPharmica (ASX: BPH) ASX Announcement

Appointment of BioPharmica CEO

BioPharmica Limited is pleased to announce that Dr Peter King has been appointed Chief Executive Officer.

Biopharmica is an ASX listed investment company, funding and managing the commercialisation of a range of biotechnology and biomedical research in Australian Universities and Medical Institutions. This is conducted either through joint ventures or through the establishment of spinout companies.

Peter was raised and educated in the UK, gaining a B.Sc in Biochemistry from the University of Bristol in 1980. He completed a Ph.D in Physical Biochemistry at the same institution in 1984. Peter subsequently joined the scientific instrumentation industry where he developed in-depth skills across multiple R&D disciplines including opto-mechanics, electronics and software engineering. As R&D manager at Applied Photophysics Ltd he led a highly qualified engineering team developing a series of innovative spectroscopic instruments now used in research chemistry and biochemistry laboratories worldwide. During this time Peter gained extensive experience in business development and general management, and in particular the analysis of commercial opportunities through collaboration with academic and industrial research institutions. In 2000 was appointed Technical Director.

In 2007 Peter moved with his family to Perth. He joined BioPharmica as Technical Development Manager in October 2007 and was appointed CEO in June 2008.

Mr David Breeze continues in his positions of Chairman and Managing Director on the Board of Directors.

For more information contact:

Mr David Breeze BioPharmica Limited Tel : +61 8 9328 8366

Dr Peter King BioPharmica Limited Tel: +61 8 9328 8366

Yours sincerely,

==> picture [127 x 46] intentionally omitted <==

David Breeze Chairman

BioPharmica Limited ACN 95 912 002 PO Box 317, North Perth Western Australia 6906 14 View Street, North Perth Western Australia 6006 [email protected] www.biopharmica.com.au

T: +61 8 9328 8366 F: +61 8 9328 8733